No Photo Available

Last Update

2016-05-01T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Robert Junkin?

Mr. Robert C. Junkin CFA

Senior Portfolio Manager

Wells Capital Management

Direct Phone: (617) ***-****       

Email: r***@***.com

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Wells Capital Management

525 Market St., 10Th Floor

San Francisco, California 94105

United States

Company Description

Wells Capital Management was formed in 1996 from existing investment management teams that have been in place since the early 1980s. We have the resources and backing of our parent company, Wells Fargo Bank, N.A., and the operational freedom to manage our ... more

Find other employees at this company (552)

Background Information

Employment History

Pm

Evergreen Investments

Vice President and Co-Portfolio Manager of the Company's Large and Mid Capitalization Growth Funds

Pioneer Investments

Finance Manager

Elan Corporation , plc

Vice President and Senior Analyst

ABN AMRO Ltd

Vice President

Pioneer Funds Distributor , Inc.

Education

bachelor's degree

economics

University of Pennsylvania

master's degree

accounting

Northeastern University

Web References (62 Total References)


Bill Rutherford Quoted in The Wall Street Journal • Rutherford Investments

rutherfordinvestment.com [cached]

"It adds a whole new element of uncertainty," says Rob Junkin, who manages Evergreen Health Care Fund.

Investors say they still see plenty of defensive plays in certain niches - and, after so many price plunges, a lot of value, too.
For instance, Mr. Junkin likes both Allergan (AGN) and Barr Pharmaceuticals (BRL) after their big share price declines. Besides Botox, Allergan has a solid and promising eye-care business, he says.


"Certain sub-sectors are much more ...

www.insurancenewsnet.com [cached]

"Certain sub-sectors are much more high-margin, and the more profitable ones may be bigger targets of the government," said Rob Junkin, senior portfolio manager of Evergreen Health Care Fund (EHABX) .

...
"Democrats can put through whatever they want" because they have the numbers in Congress, Junkin said. While he expects the Senate's proposal to be less radical than the one put forward by the House, the question is whether a public-plan option is in the final bill.
The public option would be a "pathway to getting nationalized health-care in the next five- to 10 years," Junkin predicted.
...
Evergreen's Junkin, though, warned that while hospitals should be a "net beneficiary" from any industry makeover, "there's going to be pressure on margins in most of the [health-care] sector's companies."
Chung said reform that helps hospitals earn profits will be less controversial than one that helps insurance companies, while Junkin speculated that reform would hit the managed care sector -- including insurance companies and HMOs -- harder than any other area of health care.
...
Managed care is the one area where Junkin is significantly underweight; he's most enthusiastic biotech and medical technology.
...
Junkin said cost control is a factor in the stocks he likes -- companies that can help cut costs are likely to be popular. Health-care technology provider Cerner Corp. (CERN) is one such outfit, he said, as streamlining systems should help reduce expenses.


Press Releases

www1.evergreeninvestments.com [cached]

Robert C. Junkin, CPA, and Kenneth J. Doerr have been appointed co-lead portfolio managers for Evergreen Mid Cap Growth Fund, Evergreen Small-Mid Growth Fund, and related separate accounts.


Who Shot Goldilocks by William D. Rutherford » Blog Archive » Bill Rutherford Quoted in The Wall Street Journal

www.whoshotgoldilocks.com [cached]

"It adds a whole new element of uncertainty," says Rob Junkin, who manages Evergreen Health Care Fund.

Investors say they still see plenty of defensive plays in certain niches - and, after so many price plunges, a lot of value, too.
For instance, Mr. Junkin likes both Allergan (AGN) and Barr Pharmaceuticals (BRL) after their big share price declines. Besides Botox, Allergan has a solid and promising eye-care business, he says.


"It adds a whole new element ...

www.whoshotgoldilocks.com [cached]

"It adds a whole new element of uncertainty," says Rob Junkin, who manages Evergreen Health Care Fund.

Investors say they still see plenty of defensive plays in certain niches - and, after so many price plunges, a lot of value, too.
For instance, Mr. Junkin likes both Allergan (AGN) and Barr Pharmaceuticals (BRL) after their big share price declines. Besides Botox, Allergan has a solid and promising eye-care business, he says.

Similar Profiles

Other People with this Name

Other people with the name Junkin

LeAnn Junkin
RoofConnect

Caroline Junkin
Dell Inc.

Bryan Junkin
Purdue Pharma

Krystal Junkin
University of Alabama

Ronnie Junkin
Phifer Incorporated

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory